PDL-1 Expression on Circulating Tumor Cells in Non-small Cell Lung Cancer

CompletedOBSERVATIONAL
Enrollment

216

Participants

Timeline

Start Date

October 1, 2015

Primary Completion Date

October 31, 2021

Study Completion Date

December 31, 2021

Conditions
Lung Cancer
Interventions
BIOLOGICAL

blood sample collection for CTC and MDSC analysis

"* Isolation of circulating tumor cells from 2 tubes by ISET filtration module. Peripheral blood samples will be collected for CTC analysis within 7 days before commencing treatment (defined as baseline) and following four cycles of immunotherapy,~* Analysis of PD-L1 and PD-L2 expression by immunocytochemistry on CTC~* Analysis of the expression of PD-L1, PD-L2 , CTLA4 on the histological specimen by immunohistochemistry"

Trial Locations (1)

31059

Larrey Hospital, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT02827344 - PDL-1 Expression on Circulating Tumor Cells in Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter